Ebola outbreak: US doctor Kent Brantly released from hospital
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.An American doctor who contracted Ebola treating victims of the deadly virus in Liberia has been released from a U.S. hospital after receiving treatment with an experimental drug, his charity said on Thursday.
Kent Brantly was given ZMapp, a trial drug used on a handful of patients in the West African outbreak, and flown to the United States this month. He was released from Atlanta's Emory University Hospital, according to a statement from Samaritan's Purse.
Since it was discovered in remote southeastern Guinea in March, the overall death toll from the outbreak has reached 1,350 from a total of 2,473 cases.
The Ebola outbreak is putting off thousands of tourists who had planned trips to Africa this year, especially Asians, including to destinations thousands of miles from the nearest infected community such as Kenya and South Africa.
Containing the outbreak requires large numbers of specialist staff to map the epidemic, track people who have had contact with sufferers, and to work in isolation and treatment centres.
Reuters
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments